Cargando…

Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China

Background: Studies exploring the predictive performance of major risk factors associated with future stroke events are insufficient, and a useful tool to predict individual risk is not available. Therefore, personalized advice for preventing future stroke in patients with moyamoya disease (MMD) can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Fei, Wang, Tianzhu, Yin, Haoyuan, Li, Jiaoxing, Li, Haiyan, Guo, Tongli, Zhang, Xiong, Yang, Tingting, Jie, Liang, Wu, Xiaoxin, Li, Qi, Sheng, Wenli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155507/ https://www.ncbi.nlm.nih.gov/pubmed/34054709 http://dx.doi.org/10.3389/fneur.2021.669025

Ejemplares similares

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis
por: Ye, Fei, et al.
Publicado: (2020)

N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis
por: Ye, Fei, et al.
Publicado: (2021)

RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway
por: Ye, Fei, et al.
Publicado: (2023)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Incidental Moyamoya Disease in an Elderly Patient Presenting With Acute Ischemic Pontine Stroke
por: Abou-El-Hassan, Hadi, et al.
Publicado: (2023)

A SCANO Nomogram for Individualized Prediction of the Probability of 1-Year Unfavorable Outcomes in Chinese Acute Ischemic Stroke Patients
por: Li, Xiang, et al.
Publicado: (2020)

Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya
por: Zheng, Jun, et al.
Publicado: (2019)

Development of a Nomogram for Predicting Asymptomatic Coronary Artery Disease in Patients with Ischemic Stroke
por: Yang, Jie, et al.
Publicado: (2022)

Moyamoya: An Update and Review
por: Berry, James A, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Corrigendum: A SCANO Nomogram for Individualized Prediction of the Probability of 1-Year Unfavorable Outcomes in Chinese Acute Ischemic Stroke Patients
por: Li, Xiang, et al.
Publicado: (2020)

AND score: a simple tool for predicting infection in acute ischemic stroke patients without a ventilator in the Chinese population
por: Li, Jiaoxing, et al.
Publicado: (2019)

Risk Estimation of Infectious and Inflammatory Disorders in Hospitalized Patients With Acute Ischemic Stroke Using Clinical-Lab Nomogram
por: Li, Junhong, et al.
Publicado: (2021)

A Validated Nomogram That Predicts Prognosis of Autoimmune Encephalitis: A Multicenter Study in China
por: Sun, Yueqian, et al.
Publicado: (2021)

A New Nomogram for Predicting the Risk of Intracranial Hemorrhage in Acute Ischemic Stroke Patients After Intravenous Thrombolysis
por: Weng, Ze-An, et al.
Publicado: (2022)

Acute Bilateral Stroke in a Moyamoya Patient With High Risk of Thrombosis Due to Multiple Myeloma With Chemotherapy
por: Castañeda-Hurtado, David F, et al.
Publicado: (2023)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

A Dynamic Nomogram to Predict the Risk of Stroke in Emergency Department Patients With Acute Dizziness
por: Bi, Ying, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Nomogram Including Neutrophil-to-Lymphocyte Ratio for the Prediction of Stroke-Associated Infections
por: Lan, Yan, et al.
Publicado: (2020)

A nomogram for predicting atrial fibrillation detected after acute ischemic stroke
por: Pang, Ming, et al.
Publicado: (2022)

Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Non-invasive Urinary Biomarkers in Moyamoya Disease
por: Sesen, Julie, et al.
Publicado: (2021)

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Western Moyamoya Phenotype: A Scoping Review
por: Miller, Raphael, et al.
Publicado: (2021)

Surgical Management of Failed Revascularization in Moyamoya Vasculopathy
por: Lucia, Kristin, et al.
Publicado: (2021)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Multimodal evaluation of the bloodstream alteration before and after combined revascularization for Moyamoya disease
por: Cao, Lei, et al.
Publicado: (2023)

Hemorrhagic Transformation in Ischemic Moyamoya Disease: Clinical Characteristics, Radiological Features, and Outcomes
por: Lu, Junlin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5pneo8mm6imodi4mpe89ji986